immune-onc.comHealthcareFounded: 2016Funding to Date: $143.15MM
Immune-Onc Therapeutics is a clinical-stage developer of novel biotherapeutics for cancer patients.
For more details on financing and valuation for Immune-Onc Therapeutics, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Immune-Onc Therapeutics.
To read this article and more news on Immune-Onc Therapeutics, register or login.
